Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

ABOUT
Howard (Jack) West, MD
Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Read More
Question and Answer Session with Dr. Weiss on Lung Cancer Highlights, 2011
Dr West
Author
Howard (Jack) West, MD

Here's the final piece of the webinar with our own Dr. Jared Weiss on Highlights in Lung Cancer from 2011 -- the question and answer session that followed his presentation.  Below is the transcript, figures, and the audio and video versions of the podcast.

 

Dr. Weiss Lung Cancer Highlights 2011 Q and A Transcript

Dr. Weiss Lung Cancer Highlights 2011 Q and A Session Figs

Dr. Weiss Lung Cancer Highlights 2011 Q and A Session Audio Podcast

 

I hope you find our program with Dr. Weiss interesting and helpful.

Next we'll be pushing out the discussion and presentations from the Santa Monica conference 

 

Tags
acquired resistance
afatinib
c-MET
CancerGRACE
cetuximab
EGFR mutation
GRACE
GRACEcast
Heat shock protein
HSP90
Jared Weiss
Lung Cancer
Met-MAb
MetMab
T790M

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

Understanding Multiple Myeloma: A Patient Guide
Article
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients
Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Targeted Therapies 2025
Targeted Therapies in Lung Cancer Patient Forum
Video

Forum Discussions

Recent Comments

JOIN THE CONVERSATION
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
Hi Hopish hope,  Welcome to…
By JanineT GRACE … on
Comparing which scan for swelling above clavicle and near throat - supraclavicular lymph nodes?
colon cancer and HIV
By Hopish hope on
Targeted Therapies in Lung Cancer March 2025
Thank you for sharing
By LeviDrake on
Multiple EGFR mutation lung cancer
Hi bluesun,I don't know of…
By JanineT GRACE … on